---
schema_version: "secwatch.filing_event.v1"
accession: "0001906324-22-000008"
form_type: "8-K"
ticker: "QDEL"
cik: "0001906324"
company_name: "QuidelOrtho Corp"
filed_at: "2022-08-04T23:59:59+00:00"
generated_at: "2026-06-24T04:31:49.107490+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# QuidelOrtho Q2 supplemental combined revenue $898.5M, adj EPS $2.12, up 123% YoY

## Summary
- GAAP revenue $613.4M (+247% as reported) from business combination with Ortho closed May 27, 2022.
- Supplemental combined revenue $898.5M (+37.5% constant currency); excluding COVID-19 revenue, growth 9.0%.
- GAAP diluted EPS $0.36 vs $0.45 prior year; supplemental adjusted EPS $2.12 vs $0.95 (+123%).
- Adjusted EBITDA $290.8M, margin 32.4% vs 24.8% prior year; strong double-digit growth in POC and Molecular Diagnostics.
- Foreign currency negatively impacted sales growth by ~320 bps. No formal 2022 guidance provided in release.

## SEC filing metadata
- accession: 0001906324-22-000008
- form_type: 8-K
- ticker: QDEL
- cik: 0001906324
- company_name: QuidelOrtho Corp
- filed_at: 2022-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1906324/000190632422000008/0001906324-22-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1906324/000190632422000008/qdel-20220804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001906324-22-000008
- JSON: https://secwatch.observer/filing/0001906324-22-000008.json
- Plain text: https://secwatch.observer/filing/0001906324-22-000008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.